Shifting the disease management paradigm from glucose: what are the cons?

Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S353-6. doi: 10.2337/dc09-S338.
No abstract available

Publication types

  • Comment
  • Review

MeSH terms

  • Biomarkers / blood
  • Blood Glucose / metabolism*
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / mortality
  • Diabetes Complications / prevention & control
  • Diabetes Mellitus / blood*
  • Diabetic Angiopathies / blood*
  • Diabetic Angiopathies / epidemiology
  • Diabetic Angiopathies / mortality
  • Fasting
  • Female
  • Humans
  • Insulin-Secreting Cells / physiology
  • Male
  • Obesity / prevention & control
  • Risk Factors
  • Sex Characteristics
  • Weight Gain

Substances

  • Biomarkers
  • Blood Glucose